Prion diseases are rare, deadly neurodegenerative brain diseases that result from misfolding protein. Recent study encourages the development of antibodies to PrPC to prevent its conversion to PrPSc. If successful, their unique approach illuminates treatment for prion and other like diseases
Subscribe to:
Post Comments (Atom)
< + > Why Healthcare Needs Coordinated Infrastructure, Not More Point Solutions
Cotiviti ties together providers and payers, including the top 25 US health plans, that collectively serve 300 million members in the Unite...
No comments:
Post a Comment